PHARMACOSMOS APPOINTS HENRIK PARKER AS CHIEF FINANCIAL OFFICER (CFO)

Pharmacosmos is pleased to announce Henrik Parker as its new Chief Financial Officer. Henrik succeeds Robert Guglielmetti, who has decided to step down after 19 years in the CFO role. Robert will stay with Pharmacosmos in a new role as Senior Director, Finance.

Henrik Parker is an experienced finance executive and State Authorised Public Accountant with extensive financial experience including within the pharmaceutical industry, through his former role as Corporate Vice President of Corporate Accounting at Novo Nordisk. In this role, Henrik was responsible for external financial reporting, internal financial controls, and payroll for all Danish employees, leading a department of 40 employees. 

Henrik’s other experience includes serving as Vice President of Group Reporting & FP&A at Falck Group as well as the role as interim CFO at DUOS Gruppen. Henrik started his career at KPMG, where he worked for several years in Denmark and London. 

“Following a thorough external search, we are pleased to welcome Henrik to Pharmacosmos Executive Management. I am confident that Henrik’s international experience in both pharma and other industries will benefit our organisation as we continue to grow. I would also like to thank Robert for his outstanding contributions to Pharmacosmos over the last two decades.” said Tobias S. Christiansen, President, and CEO, Pharmacosmos.